메뉴 건너뛰기




Volumn 18, Issue 1, 2016, Pages

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: A 2-year multicentre exploratory study

Author keywords

Celecoxib; Chondroitin sulfate; Knee; Osteoarthritis; Symptomatic slow acting drug in osteoarthritis

Indexed keywords

CELECOXIB; CHONDROITIN SULFATE; CYCLOOXYGENASE 2 INHIBITOR;

EID: 84993945065     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-016-1149-0     Document Type: Article
Times cited : (39)

References (53)
  • 1
    • 84871099014 scopus 로고    scopus 로고
    • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
    • Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-223.
    • (2012) Lancet , vol.380 , Issue.9859 , pp. 2197-2223
    • Murray, C.J.1    Vos, T.2    Lozano, R.3    Naghavi, M.4    Flaxman, A.D.5    Michaud, C.6    Ezzati, M.7    Shibuya, K.8    Salomon, J.A.9    Abdalla, S.10
  • 2
    • 0141920503 scopus 로고    scopus 로고
    • Burden of major musculoskeletal conditions
    • Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646-56.
    • (2003) Bull World Health Organ , vol.81 , Issue.9 , pp. 646-656
    • Woolf, A.D.1    Pfleger, B.2
  • 3
    • 84919631358 scopus 로고    scopus 로고
    • An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
    • Bruyere O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253-63.
    • (2014) Semin Arthritis Rheum , vol.44 , Issue.3 , pp. 253-263
    • Bruyere, O.1    Cooper, C.2    Pelletier, J.P.3    Branco, J.4    Luisa Brandi, M.5    Guillemin, F.6    Hochberg, M.C.7    Kanis, J.A.8    Kvien, T.K.9    Martel-Pelletier, J.10
  • 4
    • 84875410203 scopus 로고    scopus 로고
    • Current interventions in the management of knee osteoarthritis
    • Bhatia D, Bejarano T, Novo M. Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci. 2013;5(1):30-8.
    • (2013) J Pharm Bioallied Sci , vol.5 , Issue.1 , pp. 30-38
    • Bhatia, D.1    Bejarano, T.2    Novo, M.3
  • 5
    • 10744224265 scopus 로고    scopus 로고
    • EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
    • Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145-55.
    • (2003) Ann Rheum Dis , vol.62 , Issue.12 , pp. 1145-1155
    • Jordan, K.M.1    Arden, N.K.2    Doherty, M.3    Bannwarth, B.4    Bijlsma, J.W.5    Dieppe, P.6    Gunther, K.7    Hauselmann, H.8    Herrero-Beaumont, G.9    Kaklamanis, P.10
  • 12
    • 84929590566 scopus 로고    scopus 로고
    • Discrepancies in composition and biological effects of different formulations of chondroitin sulfate
    • Martel-Pelletier J, Farran A, Montell E, Verges J, Pelletier JP. Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. Molecules. 2015;20(3):4277-89.
    • (2015) Molecules , vol.20 , Issue.3 , pp. 4277-4289
    • Martel-Pelletier, J.1    Farran, A.2    Montell, E.3    Verges, J.4    Pelletier, J.P.5
  • 13
    • 59649095045 scopus 로고    scopus 로고
    • Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial
    • Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(2):524-33.
    • (2009) Arthritis Rheum , vol.60 , Issue.2 , pp. 524-533
    • Kahan, A.1    Uebelhart, D.2    Vathaire, F.3    Delmas, P.D.4    Reginster, J.Y.5
  • 16
    • 79955794264 scopus 로고    scopus 로고
    • Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
    • Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M, Pelletier JP. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis. 2011;70(6):982-9.
    • (2011) Ann Rheum Dis , vol.70 , Issue.6 , pp. 982-989
    • Wildi, L.M.1    Raynauld, J.P.2    Martel-Pelletier, J.3    Beaulieu, A.4    Bessette, L.5    Morin, F.6    Abram, F.7    Dorais, M.8    Pelletier, J.P.9
  • 17
    • 30744472413 scopus 로고    scopus 로고
    • Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants
    • Chan PS, Caron JP, Orth MW. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res. 2005;66(11):1870-6.
    • (2005) Am J Vet Res , vol.66 , Issue.11 , pp. 1870-1876
    • Chan, P.S.1    Caron, J.P.2    Orth, M.W.3
  • 19
    • 45149118604 scopus 로고    scopus 로고
    • Biochemical basis of the effect of chondroitin sulfate on osteoarthritis articular tissues
    • Monfort J, Pelletier J-P, Garcia-Giralt N, Martel-Pelletier J. Biochemical basis of the effect of chondroitin sulfate on osteoarthritis articular tissues. Ann Rheum Dis. 2008;67:735-40.
    • (2008) Ann Rheum Dis , vol.67 , pp. 735-740
    • Monfort, J.1    Pelletier, J.-P.2    Garcia-Giralt, N.3    Martel-Pelletier, J.4
  • 20
    • 70349335800 scopus 로고    scopus 로고
    • Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
    • du Souich P, Garcia AG, Verges J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009;13(8A):1451-63.
    • (2009) J Cell Mol Med , vol.13 , Issue.8 A , pp. 1451-1463
    • Souich, P.1    Garcia, A.G.2    Verges, J.3    Montell, E.4
  • 21
    • 77953775543 scopus 로고    scopus 로고
    • Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review
    • Martel-Pelletier J, Kwan Tat S, Pelletier JP. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review. Osteoarthritis Cartilage. 2010;18 Suppl 1:S7-11.
    • (2010) Osteoarthritis Cartilage , vol.18 , pp. S7-11
    • Martel-Pelletier, J.1    Kwan Tat, S.2    Pelletier, J.P.3
  • 22
    • 78649452031 scopus 로고    scopus 로고
    • An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis
    • Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Choquette D, Haraoui B, Abram F, Pelletier JP. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum. 2010;40(3):185-92.
    • (2010) Semin Arthritis Rheum , vol.40 , Issue.3 , pp. 185-192
    • Raynauld, J.P.1    Martel-Pelletier, J.2    Beaulieu, A.3    Bessette, L.4    Morin, F.5    Choquette, D.6    Haraoui, B.7    Abram, F.8    Pelletier, J.P.9
  • 25
    • 62949246527 scopus 로고
    • Radiological assessment of osteoarthosis
    • Kellgren JH, Lawrence JS. Radiological assessment of osteoarthosis. Ann Rheum Dis. 1957;16:494-502.
    • (1957) Ann Rheum Dis , vol.16 , pp. 494-502
    • Kellgren, J.H.1    Lawrence, J.S.2
  • 26
    • 84903455882 scopus 로고    scopus 로고
    • Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial
    • Lohmander LS, Hellot S, Dreher D, Krantz EF, Kruger DS, Guermazi A, Eckstein F. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;66(7):1820-31.
    • (2014) Arthritis Rheumatol , vol.66 , Issue.7 , pp. 1820-1831
    • Lohmander, L.S.1    Hellot, S.2    Dreher, D.3    Krantz, E.F.4    Kruger, D.S.5    Guermazi, A.6    Eckstein, F.7
  • 27
    • 67449128722 scopus 로고    scopus 로고
    • Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI
    • Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, Beaulieu AD, Abram F, Dorais M, Vignon E, et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis. 2009;68(6):938-47.
    • (2009) Ann Rheum Dis , vol.68 , Issue.6 , pp. 938-947
    • Raynauld, J.P.1    Martel-Pelletier, J.2    Bias, P.3    Laufer, S.4    Haraoui, B.5    Choquette, D.6    Beaulieu, A.D.7    Abram, F.8    Dorais, M.9    Vignon, E.10
  • 28
    • 84876699324 scopus 로고    scopus 로고
    • Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons
    • Wildi LM, Martel-Pelletier J, Abram F, Moser T, Raynauld JP, Pelletier JP. Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons. Arthritis Care Res (Hoboken). 2013;65(5):686-94.
    • (2013) Arthritis Care Res (Hoboken) , vol.65 , Issue.5 , pp. 686-694
    • Wildi, L.M.1    Martel-Pelletier, J.2    Abram, F.3    Moser, T.4    Raynauld, J.P.5    Pelletier, J.P.6
  • 29
    • 50849121680 scopus 로고    scopus 로고
    • A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI
    • Pelletier JP, Raynauld JP, Abram F, Haraoui B, Choquette D, Martel-Pelletier J. A new non-invasive method to assess synovitis severity in relation to symptoms and cartilage volume loss in knee osteoarthritis patients using MRI. Osteoarthritis Cartilage. 2008;16 Suppl 3:S8-13.
    • (2008) Osteoarthritis Cartilage , vol.16 , pp. S8-13
    • Pelletier, J.P.1    Raynauld, J.P.2    Abram, F.3    Haraoui, B.4    Choquette, D.5    Martel-Pelletier, J.6
  • 33
    • 77956583756 scopus 로고    scopus 로고
    • Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging
    • Li W, Abram F, Pelletier JP, Raynauld JP, Dorais M, d'Anjou MA, Martel-Pelletier J. Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging. Arthritis Res Ther. 2010;12(5):R173.
    • (2010) Arthritis Res Ther , vol.12 , Issue.5 , pp. R173
    • Li, W.1    Abram, F.2    Pelletier, J.P.3    Raynauld, J.P.4    Dorais, M.5    d'Anjou, M.A.6    Martel-Pelletier, J.7
  • 34
    • 34247551198 scopus 로고    scopus 로고
    • Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes
    • Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Beaudoin G, Choquette D, Haraoui B, Tannenbaum H, Meyer JM, Beary JF, Cline GA, et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther. 2006;8(1):R21.
    • (2006) Arthritis Res Ther , vol.8 , Issue.1 , pp. R21
    • Raynauld, J.P.1    Martel-Pelletier, J.2    Berthiaume, M.J.3    Beaudoin, G.4    Choquette, D.5    Haraoui, B.6    Tannenbaum, H.7    Meyer, J.M.8    Beary, J.F.9    Cline, G.A.10
  • 35
    • 84924911826 scopus 로고    scopus 로고
    • Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents
    • Gallagher B, Tjoumakaris FP, Harwood MI, Good RP, Ciccotti MG, Freedman KB. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med. 2015;43(3):734-44.
    • (2015) Am J Sports Med , vol.43 , Issue.3 , pp. 734-744
    • Gallagher, B.1    Tjoumakaris, F.P.2    Harwood, M.I.3    Good, R.P.4    Ciccotti, M.G.5    Freedman, K.B.6
  • 36
    • 84873648604 scopus 로고    scopus 로고
    • Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?
    • Hochberg M, Chevalier X, Henrotin Y, Hunter DJ, Uebelhart D. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? Curr Med Res Opin. 2013;29(3):259-67.
    • (2013) Curr Med Res Opin , vol.29 , Issue.3 , pp. 259-267
    • Hochberg, M.1    Chevalier, X.2    Henrotin, Y.3    Hunter, D.J.4    Uebelhart, D.5
  • 37
    • 77953736595 scopus 로고    scopus 로고
    • Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration
    • Hochberg MC. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage. 2010;18 Suppl 1:S28-31.
    • (2010) Osteoarthritis Cartilage , vol.18 , pp. S28-31
    • Hochberg, M.C.1
  • 38
    • 73649146195 scopus 로고    scopus 로고
    • Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis
    • Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30(3):357-63.
    • (2010) Rheumatol Int , vol.30 , Issue.3 , pp. 357-363
    • Lee, Y.H.1    Woo, J.H.2    Choi, S.J.3    Ji, J.D.4    Song, G.G.5
  • 39
    • 84926454571 scopus 로고    scopus 로고
    • Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
    • Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, Jan S, March L, Edmonds J, Norton R, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015;74(5):851-8.
    • (2015) Ann Rheum Dis , vol.74 , Issue.5 , pp. 851-858
    • Fransen, M.1    Agaliotis, M.2    Nairn, L.3    Votrubec, M.4    Bridgett, L.5    Su, S.6    Jan, S.7    March, L.8    Edmonds, J.9    Norton, R.10
  • 40
    • 77957342022 scopus 로고    scopus 로고
    • Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
    • Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, Reichenbach S, Trelle S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675.
    • (2010) BMJ , vol.341
    • Wandel, S.1    Juni, P.2    Tendal, B.3    Nuesch, E.4    Villiger, P.M.5    Welton, N.J.6    Reichenbach, S.7    Trelle, S.8
  • 42
    • 0038494028 scopus 로고    scopus 로고
    • Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis
    • Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 2003;163(13):1514-22.
    • (2003) Arch Intern Med , vol.163 , Issue.13 , pp. 1514-1522
    • Richy, F.1    Bruyere, O.2    Ethgen, O.3    Cucherat, M.4    Henrotin, Y.5    Reginster, J.Y.6
  • 43
    • 84861821039 scopus 로고    scopus 로고
    • Interpretation of metaanalyses: pitfalls should be more widely recognized
    • Henrotin YE. Interpretation of metaanalyses: pitfalls should be more widely recognized. J Rheumatol. 2012;39(6):1107-9.
    • (2012) J Rheumatol , vol.39 , Issue.6 , pp. 1107-1109
    • Henrotin, Y.E.1
  • 44
    • 85047683313 scopus 로고    scopus 로고
    • Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique
    • Rainsford KD. Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique. J Pharm Pharmacol. 2009;61(10):1263-70.
    • (2009) J Pharm Pharmacol , vol.61 , Issue.10 , pp. 1263-1270
    • Rainsford, K.D.1
  • 45
    • 84955714059 scopus 로고    scopus 로고
    • Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: data from the OAI progression cohort
    • Roubille C, Martel-Pelletier J, Abram F, Dorais M, Delorme P, Raynauld JP, Pelletier JP. Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: data from the OAI progression cohort. Semin Arthritis Rheum. 2015;45(3):257-67.
    • (2015) Semin Arthritis Rheum , vol.45 , Issue.3 , pp. 257-267
    • Roubille, C.1    Martel-Pelletier, J.2    Abram, F.3    Dorais, M.4    Delorme, P.5    Raynauld, J.P.6    Pelletier, J.P.7
  • 47
    • 84879141778 scopus 로고    scopus 로고
    • Total knee replacement as a knee osteoarthritis outcome: predictors derived from a 4 year long-term observation following a randomized clinical trial using chondroitin sulfate
    • Raynauld JP, Martel-Pelletier J, Dorais M, Haraoui B, Choquette D, Abram F, Beaulieu A, Bessette L, Morin F, Wildi LM, et al. Total knee replacement as a knee osteoarthritis outcome: predictors derived from a 4 year long-term observation following a randomized clinical trial using chondroitin sulfate. Cartilage. 2013;4(3):219-26.
    • (2013) Cartilage , vol.4 , Issue.3 , pp. 219-226
    • Raynauld, J.P.1    Martel-Pelletier, J.2    Dorais, M.3    Haraoui, B.4    Choquette, D.5    Abram, F.6    Beaulieu, A.7    Bessette, L.8    Morin, F.9    Wildi, L.M.10
  • 48
    • 77953809438 scopus 로고    scopus 로고
    • Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study
    • Moller I, Perez M, Monfort J, Benito P, Cuevas J, Perna C, Domenech G, Herrero M, Montell E, Verges J. Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage. 2010;18 Suppl 1:S32-40.
    • (2010) Osteoarthritis Cartilage , vol.18 , pp. S32-40
    • Moller, I.1    Perez, M.2    Monfort, J.3    Benito, P.4    Cuevas, J.5    Perna, C.6    Domenech, G.7    Herrero, M.8    Montell, E.9    Verges, J.10
  • 49
    • 84865121703 scopus 로고    scopus 로고
    • Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum®
    • Schneider H, Maheu E, Cucherat M. Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum®. Open Rheumatol J. 2012;6:183-9.
    • (2012) Open Rheumatol J , vol.6 , pp. 183-189
    • Schneider, H.1    Maheu, E.2    Cucherat, M.3
  • 50
    • 84930510761 scopus 로고    scopus 로고
    • Placebo effect in osteoarthritis: Why not use it to our advantage?
    • de Campos GC. Placebo effect in osteoarthritis: Why not use it to our advantage? World J Orthop. 2015;6(5):416-20.
    • (2015) World J Orthop , vol.6 , Issue.5 , pp. 416-420
    • Campos, G.C.1
  • 51
    • 84879822928 scopus 로고    scopus 로고
    • A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis
    • Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford). 2013;52(7):1303-12.
    • (2013) Rheumatology (Oxford) , vol.52 , Issue.7 , pp. 1303-1312
    • Conaghan, P.G.1    Dickson, J.2    Bolten, W.3    Cevc, G.4    Rother, M.5
  • 52
    • 33847420941 scopus 로고    scopus 로고
    • Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
    • Bingham 3rd CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford). 2007;46(3):496-507.
    • (2007) Rheumatology (Oxford) , vol.46 , Issue.3 , pp. 496-507
    • Bingham, C.O.1    Sebba, A.I.2    Rubin, B.R.3    Ruoff, G.E.4    Kremer, J.5    Bird, S.6    Smugar, S.S.7    Fitzgerald, B.J.8    O'Brien, K.9    Tershakovec, A.M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.